Home

ventilare Sus extinde marker tumoral s 200 Sigur închis deficit

Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future

PLA1A expression as a diagnostic marker of BRAF-mutant metastasis in  melanoma cancer | Scientific Reports
PLA1A expression as a diagnostic marker of BRAF-mutant metastasis in melanoma cancer | Scientific Reports

Spatial immunophenotypes predict response to anti-PD1 treatment and capture  distinct paths of T cell evasion in triple negative breast cancer | Nature  Communications
Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer | Nature Communications

Single-cell analysis defines a pancreatic fibroblast lineage that supports  anti-tumor immunity - ScienceDirect
Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity - ScienceDirect

Transcriptome profile of the early stages of breast cancer tumoral  spheroids | Scientific Reports
Transcriptome profile of the early stages of breast cancer tumoral spheroids | Scientific Reports

Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor  Microenvironment - ScienceDirect
Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - ScienceDirect

Tumor Marker Tests | Cancer.Net
Tumor Marker Tests | Cancer.Net

Frontiers | Multi-Parameter Quantitative Imaging of Tumor Microenvironments  Reveals Perivascular Immune Niches Associated With Anti-Tumor Immunity
Frontiers | Multi-Parameter Quantitative Imaging of Tumor Microenvironments Reveals Perivascular Immune Niches Associated With Anti-Tumor Immunity

Quantification of tumor heterogeneity: from data acquisition to metric  generation: Trends in Biotechnology
Quantification of tumor heterogeneity: from data acquisition to metric generation: Trends in Biotechnology

Signaling Pathways and Targeted Therapies for Stem Cells in Prostate Cancer  | ACS Pharmacology & Translational Science
Signaling Pathways and Targeted Therapies for Stem Cells in Prostate Cancer | ACS Pharmacology & Translational Science

Objective assessment of tumor infiltrating lymphocytes as a prognostic  marker in melanoma using machine learning algorithms - eBioMedicine
Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms - eBioMedicine

Genetic dissection of the miR-200–Zeb1 axis reveals its importance in tumor  differentiation and invasion | Nature Communications
Genetic dissection of the miR-200–Zeb1 axis reveals its importance in tumor differentiation and invasion | Nature Communications

Suppression of tumor-associated neutrophils by lorlatinib attenuates  pancreatic cancer growth and improves treatment with immune checkpoint  blockade | Nature Communications
Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade | Nature Communications

Multi-scale characterization of tumor-draining lymph nodes in resectable  lung cancer treated with neoadjuvant immune checkpoint inhibitors -  eBioMedicine
Multi-scale characterization of tumor-draining lymph nodes in resectable lung cancer treated with neoadjuvant immune checkpoint inhibitors - eBioMedicine

Targeting primary and metastatic tumor growth in an aggressive breast  cancer by engineered tryptophan auxotrophic Salmonella Typhimurium:  Molecular Therapy - Oncolytics
Targeting primary and metastatic tumor growth in an aggressive breast cancer by engineered tryptophan auxotrophic Salmonella Typhimurium: Molecular Therapy - Oncolytics

A heparan-sulfate-bearing syndecan-1 glycoform is a distinct surface marker  for intra-tumoral myeloid-derived suppressor cells - ScienceDirect
A heparan-sulfate-bearing syndecan-1 glycoform is a distinct surface marker for intra-tumoral myeloid-derived suppressor cells - ScienceDirect

In vivo flow cytometry reveals a circadian rhythm of circulating tumor  cells | Light: Science & Applications
In vivo flow cytometry reveals a circadian rhythm of circulating tumor cells | Light: Science & Applications

Cancers | Free Full-Text | Multiparametric Phenotyping of Circulating Tumor  Cells for Analysis of Therapeutic Targets, Oncogenic Signaling Pathways and  DNA Repair Markers | HTML
Cancers | Free Full-Text | Multiparametric Phenotyping of Circulating Tumor Cells for Analysis of Therapeutic Targets, Oncogenic Signaling Pathways and DNA Repair Markers | HTML

Frontiers | Expression Profiles and Prognostic Value of Multiple Inhibitory  Checkpoints in Head and Neck Lymphoepithelioma-Like Carcinoma
Frontiers | Expression Profiles and Prognostic Value of Multiple Inhibitory Checkpoints in Head and Neck Lymphoepithelioma-Like Carcinoma

Rapid Assessment of Surface Markers on Cancer Cells Using Immuno-Magnetic  Separation and Multi-frequency Impedance Cytometry for Targeted Therapy |  Scientific Reports
Rapid Assessment of Surface Markers on Cancer Cells Using Immuno-Magnetic Separation and Multi-frequency Impedance Cytometry for Targeted Therapy | Scientific Reports

Markeri tumorali in bolile digestive 0758751841 Cabinet privat de  gastroenterologie si hepatologie Bucuresti | 0758751841 Cabinet privat de  gastroenterologie si hepatologie Bucuresti
Markeri tumorali in bolile digestive 0758751841 Cabinet privat de gastroenterologie si hepatologie Bucuresti | 0758751841 Cabinet privat de gastroenterologie si hepatologie Bucuresti

Markeri tumorali in bolile digestive 0758751841 Cabinet privat de  gastroenterologie si hepatologie Bucuresti | 0758751841 Cabinet privat de  gastroenterologie si hepatologie Bucuresti
Markeri tumorali in bolile digestive 0758751841 Cabinet privat de gastroenterologie si hepatologie Bucuresti | 0758751841 Cabinet privat de gastroenterologie si hepatologie Bucuresti

Pericytes augment glioblastoma cell resistance to temozolomide through  CCL5-CCR5 paracrine signaling | Cell Research
Pericytes augment glioblastoma cell resistance to temozolomide through CCL5-CCR5 paracrine signaling | Cell Research

Frontiers | Blood-Brain Barrier, Blood-Brain Tumor Barrier, and  Fluorescence-Guided Neurosurgical Oncology: Delivering Optical Labels to  Brain Tumors
Frontiers | Blood-Brain Barrier, Blood-Brain Tumor Barrier, and Fluorescence-Guided Neurosurgical Oncology: Delivering Optical Labels to Brain Tumors

Single-cell evaluation reveals shifts in the tumor-immune niches that shape  and maintain aggressive lesions in the breast | Nature Communications
Single-cell evaluation reveals shifts in the tumor-immune niches that shape and maintain aggressive lesions in the breast | Nature Communications